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Crosslinked copolymers of various compositions of N-vinyl-2-pyrrolidone (VP) and 2-hydroxyethyl
methacrylate (HEMA) were prepared chemically in the presence of a crosslinking agent. The swelling
mechanism was non-Fickian with about 86% conversion of feed composition to crosslinked copolymer.
The reactivity ratios r1 = 0.045 and r2 = 3.07 for VP and HEMA indicate that HEMA is more reactive
than VP in the reaction. Hydrophilicity, hydrophobicity and monomer composition in the copolymer
controlled the drug release from the hydrogels.
Key Words: N-vinyl-2-pyrrolidone, 2-hydroxyethyl methacrylate, Hydrogels, Drug release.

Introduction
Interest in the preparation of hydrogels due to their use in contact lenses, controlled release, biotechnology
and other fields of life has increased considerably in recent years1−6 . However, the number of polymers suitable for controlled release is quite limited compared to the total available synthetic polymers because of the
lack of certain properties like biodegradability, swellability and non or less toxicity in specific environments.
We have reported previously7−9 on the preparation, properties and controlled release of hydrogels
based on N-vinyl-2-pyrrolidone (VP) and some others with comonomers. High conversion for copolymerisation was obtained and the overall degree of equilibrium swelling in water was found to cover a wide range
according to the nature and content of the comonomer.
HEMA/VP copolymer has been prepared by different methods10−12 using γ-radiation but due, to a
lack of certain properties which are greatly dependent on the monomer contents and crosslinking extents, it
∗ Correspondence

author

279

Chemically Crosslinked N-Vinyl-2-Pyrrolidone/2-Hydroxyethyl..., B. AHMAD, et al.,

could not be used every time for controlled release. However, linear HEMA/VP copolymer was successfully
used for the controlled release of certain drugs like theophylline and erythromycin by Koresmeyer and
Peppas4 and Ahmad et al.8, respectively. Lee13 studied the release of thiamine HCl, and progesterone from
its beads and sheets whereas, Graham et al.14 prepared pessaries containing prostaglandin E2 in a matrix
of the copolymer. The mechanism of release was one of “melting out” of crystallites as a result of swelling.
All these applications of polymers and copolymers in medicine enhanced the current interest in controlled
release technology.
In the present work VP/HEMA copolymers with varying comonomer compositions were prepared using azo-isobutyronitrile (AIBN) as an initiator and N-N methylene bis acryl amide (MBA) as a crosslinker.
These hydrogels were characterised with respect to reactivity ratio, conversion, and swelling/diffusion properties and later evaluated for the potential controlled release of a cyclic oligopeptide called cyclosporine.

Experimental
a) Chemicals
NVP (Aldrich Chemical Co) and HEMA (Sigma Chemical Co) were vacuum distilled at 68 ◦ C/2.0
mmHg and 67 ◦ C/3.5 mmHg, respectively. Cyclosporine A (C62 H111N11 O12 ) of molecular weight 1202
g/mol was purchased from the Fluke–Aldrich Co. UK, and AIBN, the initiator from Sigma, was purified
by recrystallisation from toluene. N, N methylene bis acrylamide was used as a crosslinker without further
purification.
b) Polymerisation
Mixtures of NVP and HEMA in the volume ratios 4:6, 5:5, 6:4, 7:3, 8:2 and 9:1 were initiated with
0.25 wt% AIBN and 0.35 wt% crosslinker. These ratios of VP/HEMA will be designated hereafter as
VP4/HEMA6, VP5/HEMA5, VP6/HEMA4, VP7/HEMA3, VP8/HEMA2 and VP9/HEMA1, respectively.
The reaction mixtures were degassed with nitrogen for 15 min to remove the oxygen that acts as a chainterminating agent. We sealed the vials and bulk co-polymerisation was carried out at 50 ± 0.5 ◦ C for 2 h,
at 60 ± 0.5 ◦ C for 3 h, at 70 ± 0.5 ◦ C overnight and at 80 ± 0.5 ◦ C for 12 h in a water bath maintained
at polymerisation temperature. After this the vials were removed from the bath, cut away from the glassy
polymer and discs 2.0 mm thick were separated/prepared from it.
c) Conversion
After polymerisation the discs were swollen to equilibrium in deionised water at 37 ◦ C over 3 days
during which the water was changed twice a day in order to remove any possible unreacted monomers or
linear polymer. These samples were dried to constant weight at 40 ◦ C in an oven and 45 ◦ C in a vacuum
oven. The quantity m1 is the mass of the crosslinked copolymer (xerogel) and the ratio of m1 to known mass
(mo ) of (NVP + HEMA + AIBN) in the feed mixture represents the fractional conversion to crosslinked
copolymer. The ratio (r) represents the minimum value of the conversion of monomers.
r = m1 /mo
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d) Analysis of copolymer
For all the systems, the VP contents were determined by analysis using Tecator Kjeltec autoanalyser
on 0.05–0.08 g at the maximum operation temperature. The method adopted in this laboratory is reported
elsewhere15−16 . For the VP/HEMA copolymer, the –OH group content was analysed using a sample of 0.1
g, the procedure being indicated elsewhere17 .
e) Swelling kinetics
The swelling kinetics of the hydrogels was measured gravimetrically. The xerogel of weighing (w1 )
was immersed in distilled water, periodically removed from the water, surface dried lightly and weighed (w2 )
and water uptake capability was calculated as
Wu = 100(w2 − w1 )/we

(2)

where we is the weight of the hydrogel at equilibrium swelling
f ) Loading/release of drug
Polymer discs were loaded with cyclosporine in an aqueous/ethanol mixture for longer than the
equilibrium swelling time. The concentration of the drug solution was 5–10% wt/wt of the dry polymer
xerogel. The swollen drug loaded gels were dried at 25 ± 0.5 ◦ C in a vacuum oven. The drug release
experiments were performed in the same medium at a particular temperature, and the drug concentration
in release medium was monitored by its absorbance using a Hitachi model U-2000 spectrophotometer.

Results and Discussion
a) Reactivity ratio
The Mayo–Lewis18, Fineman–Ross19 and Keler–Tudos20 graphical methods were used to determine
the reactivity ratios r1 and r2 for VP/HEMA system and the values are given in Table 1.
Table 1. Reactivity ratio of VP/HEMA copolymer.

Method
1: Mayo-Lewis
2: Fineman–Ross
3: Kelen–Tudos
Average value
5: Al-Essa

VP / HEMA
r1
r2
0.018
2.88
0.088
3.37
0.029
2.95
0.045 ± 0.82 3.07 ± 0.35
0. 05 ± 0.09 3.12 ± 0.38

Reference
present work
=
=
15

The values of r1 and r2 from method (2) are high but the average values are in good agreement with
those reported15 , i.e. r1 = 0.05 and r2 = 3.12. r1 = 0.045 and r2 = 3.07 indicate that HEMA is more reactive
in the copolymerisation and the copolymer structure will be random coil in nature.
b) Conversion
The solution copolymerisations with different composition of VP/HEMA afforded a minimum of 85.8%
for xerogel of high HEMA mole fraction based on 0.35 wt% MBA. We synthesised (unpublished data) the
crosslinked PVP alone with the same crosslinker by inverse suspension polymerisation and conversion was
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68%. This high mean HEMA content enhanced the conversion of copolymer. The discs were assessed visually
for optical homogeneity and were found clear although there was considerable compositional heterogeneity
in the feed mixture. In an earlier report21 on HEMA/VP copolymerisation involving calculation of compositional heterogeneity via a form of the Skeist procedure22 , a plot was given of fractional conversion vs.
composition as expressed by the mole fraction of VP in the copolymer. This showed that HEMA enters the
copolymer faster than VP due to its high reactivity, and thus the product has a composition very close to
that of PVP homopolymer in the latter stages of conversion. The higher the VP contents in the feed, the
lower the conversion at which HEMA is totally consumed.
The swelling behaviour of copolymers with different VP/HEMA compositions was first characterised
without a model drug because this swelling is the key factor describing drug diffusion in the gels, the
swelling ratio trend with time is shown in figure 1. The rate of water uptake is faster for feed composition
(VP9/HEMA1) having higher VP content than for that having lower VP and higher HEMA (VP1/HEMA9).
Huglin et al.23,24 observed that by increasing VP content in copolymers, the cross-linking efficiency decreases,
while copolymers of higher HEMA are more crosslinked due to the presence of diester in the HEMA monomer.
In the present case, for the same reason of higher hydrophilicity due to VP, the VP9/HEMA1 has higher
water uptake and 93% water uptake was reached within 4 h, while for the high content HEMA copolymer
VP4/ HEMA6 water uptake was only 15% and hence took longer time.
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Figure 1. Variation of percentage water uptake with time (h) for various compositions of VP/HEMA copolymer.

The effect of temperature on dimensions was studied for only one particular hydrogel, i.e that prepared
in VP6/HEMA4 and measurable decrease of 7.16% was noted over an increase of 310–340 K = 30 K, which
corresponds to 0.25% per Kelvin.
Furthermore, the following equation was used to determine the nature of diffusion of water into
hydrogel25 :
Mt /Me = ktn

(3)

Mt /Me is the fractional water uptake, t is the diffusion time, n is the transport mode for the penetrant
and k is a constant related to the structure of the network. Value n = 0.45– 0.50 corresponds to Fickian
diffusion whereas 0.50 < n > 1.0 shows non-Fickian diffusion26 . The values of n obtained from the slope of
the plot of log Mt /Me vs. logt are given in Table 2. For all compositions the value varies between 0.55 and
0.67, showing non-Fickian diffusion.
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Drug release
The drug loaded dry gels were equilibrated in the medium and the drug concentration was monitored at 37
◦

C. It has been assessed27 that swelling, not only in water but also in ethanol and chloroform, decreases
at increasing temperature and the opposite effect prevailed for swelling in nonhydrogen bonding liquids.
This behaviour will ultimately affect the release of the drug and so we selected 37 ◦ C, body temperature.
The release of cyclosporine from the discs is shown in figure 2. The release is seen to be dependent on
copolymer composition. Likewise, the samples containing the smallest amounts of the most hydrophilic
NVP component and larger quantities of HEMA exhibit slow release. The release is considerably faster as
the NVP content increases, i.e. after 4 h, 66% of the drug is released to the medium for VP9/HEMA1,
whereas for VP4/HEMA6 the release is only 11%. At the start, the release is controlled by the PVP
fraction due to its rapid swelling, while the later stage is related to the hydrophilic/hydrophobic balance
of the residual HEMA rich copolymer and thus permeabilities and diffusion parameters have to be taken
into account. The release is independent of the incubation time. A cyclosporine release experiment was
recently undertaken by Gallardo et al.28 through a linear uncross linked copolymer on the basis of solubility
difference and microstructural distribution but the burst effect of the linear copolymer with high HEMA
content restricts its use for controlled release. The crosslinked VP/HEMA copolymer is stable as reported4
for the release of theophylline.
Table 2. Diffusion coefficient values for different systems.

System
VP4/HEMA6
VP5/HEMA5
VP6/HEMA4
VP7/HEMA3
VP8/HEMA2
VP9/HEMA1

1
2
3
4
5
6

n
0.55
0.56
0.58
0.59
0.62
0.67

correlation coefficient
0.9993
0.9995
0.9951
0.9981
0.9972
0.9985
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Figure 2. Variation of drug release with time (h) for different compositions of VP/ HEMA copolymer at 37 ◦ C.

Conclusion
1. VP/HEMA copolymer was crosslinked by a chemical method rather than by the γ-radiation commonly
used.
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2. 86% conversion of feed composition into crosslinked copolymer was obtained.
3. The reactivity ratio for VP/HEMA is r1 = 0.045 and r2 = 3.07.
4. The diffusion coefficient values for all compositions are above 0.55, indicating non-Fickian mode of
diffusion.
5. The VP/HEMA contents of the copolymer controlled the release of cyclosporine in the initial and later
stages respectively.
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